BioSerenTach Inc 本文へジャンプ

BioSerenTach is aggressively and globally looking for partners.

We actively look for partners which suffer from bioavailability problem of API.

BioSerenTach codevelops suitable formulations for API with our DDS technologies.

BioSerenTach Inc.
Head office Shimizu-cho 389, Nakagyo-ku, Kyoto 604-0874, Japan
Tel 075-746-2160 (from abroad 81-75-746-2160)
Fax 075-746-2160 (from abroad 81-75-746-2160)
Established August 1, 2001
Chairman Prof. Kanji Takada, Ph. D. 
President Yasuyo Takada
Capitalization ¥10,000,000
Main Bank Kyoto Bank

Copyright BioSerenTach Inc, 2021